CFAI
C.F.A.I.
Government Data Intelligence Services

BIOCON PHARMA INC

Company NJ
Found in 2 federal databases · 6 total records
fda 2 records
FDA Drug Recall: Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured 2025-04-09
Class II — Failed dissolution specifications: lower than specifications
View Source
FDA Drug Recall: Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufact 2023-02-15
Class II — Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
View Source
fda_adverse 4 records
FDA AE Manufacturer: Biocon Pharma Inc,
Drug adverse event reporter — Product: SIMVASTATIN
View Source
FDA AE Manufacturer: Biocon Pharma Inc
Drug adverse event reporter — Product: ROSUVASTATIN CALCIUM
View Source
FDA AE Manufacturer: Biocon Pharma Inc.
Drug adverse event reporter — Product: FAMOTIDINE
View Source
FDA AE Manufacturer: BIOCON PHARMA INC.,
Drug adverse event reporter — Product: LENALIDOMIDE
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.